Proposed Additional Agenda Item for July 12, 2005 ICOC Meeting 7/12/05
|
Notice of Proposed Additional Agenda Item REGULAR MEETING OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”) TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (“CIRM”) Organized Pursuant To The CALIFORNIA STEM CELL RESEARCH AND CURES ACT Tuesday, July 12, 2005 8:00 AM-5:30 PM (Estimated) Location UCI University Club University of California, Irvine 801 East Peltason Drive Irvine, CA 92697
Additional agenda item (Government Code section 11125.3(b)): Consideration of motion adopted by the Scientific and Medical Accountability Standards Working Group (Standards Working Group) requesting that the ICOC amend its motion adopting the NAS Guidelines on Human Stem Cell Research to direct the Standards Working Group to convert the Guidelines into regulatory language and make changes necessary to conform the Guidelines to California law and propose this language to the ICOC for its consideration as interim standards at the ICOC’s September 9, 2005 meeting, and to commence the formal rule making process under the Administrative Procedure Act if and after the ICOC adopts this language as its interim standards.
**NOTICE** The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 510-450-2418 no later than the day prior to the meeting, or by Telecommunication Device for the Deaf (TDD) services at 916-324-6547.
Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 510-450-2418.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.
|